A comprehensive guide to risk-based validation approaches for pharmaceutical and medical device manufacturing, providing strategies to prioritize validation efforts based on product risk.
Risk Based Validation Strategies for the Development of Drugs and Devices
Original price was: $375.00.$315.00Current price is: $315.00.
9999 in stock
9999 in stock
Description
This comprehensive white paper provides a detailed roadmap for adopting risk-based approaches to equipment and process validation in pharmaceutical and medical device manufacturing. Featuring updated 2024-2025 regulatory guidance including Computer Software Assurance (CSA), AI-Enabled Device Software validation, and ICH Q12/Q13 implementation, this guide helps manufacturers streamline operations, reduce costs, and ensure delivery of safe and effective products. Learn 14 key strategies including establishing cross-functional teams, defining risk acceptance criteria, employing formal risk assessment tools, and leveraging historical data. Includes comprehensive metrics for measuring validation strategy effectiveness and alignment with current FDA enforcement trends.
